Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease
- PMID: 12088093
- DOI: 10.1515/reveh.2002.17.1.51
Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease
Abstract
Parkinson's disease (PD) is a common neurodegenerative disease characterized by dopaminergic cell death and deposition of Lewy bodies within the substantia nigra of the midbrain. Although the major risk factors for PD are aging and environmental factors, there is an important genetic component. An age-related change in xenobiotic metabolism alters the metabolism of and net exposure to, environmental neurotoxins. Genetic variability in xenobiotic metabolism may similarly increase the susceptibility to PD by altering the metabolism of neurotoxins. Genetic studies of rare familial cases of PD indicate a central mechanistic role for the aggregation of alpha-synuclein, a protein found in Lewy bodies. Environmental factors like pesticides and heavy metals can also influence alpha-synuclein aggregation. Common final pathways for aging, environmental, and genetic mechanisms can thus exist, involving both direct neurotoxicity and alpha-synuclein aggregation.
Similar articles
-
Pathogenesis of Parkinson's disease.Curr Opin Investig Drugs. 2001 May;2(5):657-62. Curr Opin Investig Drugs. 2001. PMID: 11569943 Review.
-
Genes, proteins, and neurotoxins involved in Parkinson's disease.Prog Neurobiol. 2004 Jun;73(3):151-77. doi: 10.1016/j.pneurobio.2004.05.002. Prog Neurobiol. 2004. PMID: 15236834 Review.
-
Mechanistic approaches to Parkinson's disease pathogenesis.Brain Pathol. 2002 Oct;12(4):499-510. doi: 10.1111/j.1750-3639.2002.tb00468.x. Brain Pathol. 2002. PMID: 12408237 Free PMC article. Review.
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
-
Molecular pathogenesis of Parkinson disease.Arch Neurol. 2005 Mar;62(3):353-7. doi: 10.1001/archneur.62.3.353. Arch Neurol. 2005. PMID: 15767499 Review.
Cited by
-
Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease.Neuroscience. 2013 Aug 29;246:382-90. doi: 10.1016/j.neuroscience.2013.04.037. Epub 2013 Apr 25. Neuroscience. 2013. PMID: 23623990 Free PMC article.
-
Non-Motor Symptoms after One Week of High Cadence Cycling in Parkinson's Disease.Int J Environ Res Public Health. 2019 Jun 14;16(12):2104. doi: 10.3390/ijerph16122104. Int J Environ Res Public Health. 2019. PMID: 31197095 Free PMC article. Clinical Trial.
-
Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration.Mol Pharmacol. 2010 Apr;77(4):621-32. doi: 10.1124/mol.109.062174. Epub 2010 Jan 22. Mol Pharmacol. 2010. PMID: 20097775 Free PMC article.
-
GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease.BMC Bioinformatics. 2006 Jan 25;7:39. doi: 10.1186/1471-2105-7-39. BMC Bioinformatics. 2006. PMID: 16436204 Free PMC article.
-
NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease.PLoS One. 2011;6(7):e21907. doi: 10.1371/journal.pone.0021907. Epub 2011 Jul 1. PLoS One. 2011. PMID: 21747966 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical